Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04763109 · ClinicalTrials.gov registry record · NA
Identification of Pre-Malignant Lesions In Pediatric Patients With Neurofibromatosis Type 1 Using Novel Magnetic Resonance Imaging Techniques Paired With Artificial Intelligence
A NA study of Neurofibromatosis Type 1, sponsored by Nicole Baca.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT04763109 is a NA study of Neurofibromatosis Type 1 that is actively recruiting participants, run by Nicole Baca. The registered enrollment target is 15 participants, below the 160-participant average among 17 other Neurofibromatosis Type 1 trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04763109, a NA study of Neurofibromatosis Type 1, is actively recruiting participants, sponsored by Nicole Baca.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single arm pilot trial of a novel whole-body Magnetic Resonance Imaging paired with artificial intelligence intervention, to evaluate feasibility defined as scan-rescan reliability, and to estimate the positive predictive value of changes in Magnetic Resonance Imaging scans from baseline to 12-month visit using an Artificial Intelligence algorithm, among 15 pediatric patients with neurofibromatosis type 1 at Cedars-Sinai Medical Center.
Conditions Studied
Interventions
- OTHER Whole-body Magnetic Resonance Imaging
Study Locations (1)
California
- Cedars Sinai Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2022-07-08 |
| Est. Completion | 2027-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04763109
The ClinicalTrials.gov registry entry for NCT04763109 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 160-participant average among 17 other Neurofibromatosis Type 1 trials with a reported enrollment target (91% lower). The listed sponsor is Nicole Baca, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neurofibromatosis Type 1 appearing as the primary indexed condition, and to 1 intervention - of which Whole-body Magnetic Resonance Imaging is the first listed.
NCT04763109 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04763109 about?
NCT04763109 is a clinical study titled "Identification of Pre-Malignant Lesions In Pediatric Patients With Neurofibromatosis Type 1 Using Novel Magnetic Resonance Imaging Techniques Paired With Artificial Intelligence". This is a single arm pilot trial of a novel whole-body Magnetic Resonance Imaging paired with artificial intelligence intervention, to evaluate feasibility defined as scan-rescan reliability, and to estimate the positive predictive value of changes in Magnetic Resonance Imaging scans from baseline t...
What is the current status of trial NCT04763109?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2022-07-08. Estimated completion is 2027-05.
What conditions does trial NCT04763109 study?
This clinical trial studies the following conditions: Neurofibromatosis Type 1.
What interventions are being tested in trial NCT04763109?
The interventions under investigation include: Whole-body Magnetic Resonance Imaging (OTHER).
Who is sponsoring clinical trial NCT04763109?
This trial is sponsored by Nicole Baca, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04763109 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neurofibromatosis Type 1
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)
RECRUITING · NA
-
Efficacy of Computerized Cognitive Training and Stimulant Medication in Neurofibromatosis Type 1
COMPLETED · NA
-
Development of Patient-Reported Outcome Measures Assessing Tumor Visibility and Appearance Concerns in Neurofibromatosis Type 1: A Qualitative Study
RECRUITING
-
Neurofibromatosis Type 1 Tumor Early Detection Study
RECRUITING
-
A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
RECRUITING · Phase 2
-
Natural History Study of Patients With Neurofibromatosis Type I
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.